STOK vs XPEV · rev $15.6M vs rev $895.7M
Stoke Therapeutics Inc (STOK) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
STOK currently screens at market cap $1.88B. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the STOK and XPEV stock pages for the full models.
Not investment advice.